National Institute for Occupational Safety and Health Advisory Board on Radiation and Worker Health, 12201-12202 [E6-3347]

Download as PDF Federal Register / Vol. 71, No. 46 / Thursday, March 9, 2006 / Notices Naturally occurring phytoestrogen, found in soy products. • TR 545: Genistein (CASNR 446–72– 0)—2-year Bioassay. Naturally occurring phytoestrogen, found in soy products. • TR 543: a-Methylstyrene (CASNR 98– 83–9). • Used in the production of resins and polymers. • TR 540: Methylene blue trihydrate (CAS No. 7220–79–3). • Dye used to stain tissues and bacteriological samples for microscopy and an antidote for methemoglobinemia; previously used as a hair colorant. [FR Doc. E6–3317 Filed 3–8–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: National Institute for Occupational Safety and Health (NIOSH) Support for Conferences and Scientific Meetings, Request for Applications PAR 06–014 hsrobinson on PROD1PC70 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): NIOSH Support for Conferences and Scientific Meetings, Request for Applications PAR 06–014. Time and Date: 1 p.m.–4 p.m., March 29, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to NIOSH Support for Conferences and Scientific Meetings, Request for Applications PAR 06–014. For More Information Contact: George Bockosh, MS, Scientific Review Administrator, National Institute for Occupational Safety and Health, CDC, 626 Cochran Mill Road, MS PO–5, Pittsburgh, PA 15236, Telephone 412–386–6465. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. 13:58 Mar 08, 2006 Jkt 208001 BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting: BILLING CODE 4140–01–P VerDate Aug<31>2005 Dated: March 3, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–3354 Filed 3–8–06; 8:45 am] Name: National Center for Injury Prevention and Control (NCIPC) Initial Review Group (IRG). Times and Dates: 6:30 p.m.–10 p.m., April 10, 2006. 8:30 a.m.–6 p.m., April 11, 2006. 8 a.m.–5:30 p.m., April 12, 2006. Place: Hilton Atlanta Airport and Towers, 1031 Virginia Avenue, Atlanta, Georgia 30354. Status: Open: 6:30 p.m.–7:15 p.m., April 10, 2006. Closed: 7:15 p.m. to 10 p.m., April 10, 2006. 8:30 a.m. to 6 p.m., April 11, 2006. 8 a.m. to 5:30 p.m., April 12, 2006. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS) and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including state and local government agencies, to conduct specific injury research that focuses on injury prevention and control. Matters to be Discussed: Agenda items include an overview of the injury program, discussion of the review process and panelists responsibilities, and the review of, and vote on, applications. Beginning at 7:15 p.m., April 10, through 5:30 p.m., April 12, the Group will review individual research grant and cooperative agreement applications submitted in response to six Fiscal Year 2006 Requests for Applications (RFAs) related to the following individual research announcements: #06001, Research Grants to Prevent Unintentional Injuries; #06002, Dissertation Grant Awards for ViolenceRelated Injury Prevention Research in Minority Communities; #06003, Research Grants to Describe Traumatic Brain Injury Consequences; #06004, Grants for ViolenceRelated Injury Prevention Research: Youth Violence, Suicidal Behavior, Child Maltreatment, Intimate Partner Violence, and Sexual Violence; #06005, Research Grants for the Care of the Acutely Injured; #06007, Evaluation of Community-based Approaches to Increasing Seat Belt Use Among Adolescent Drivers and Their Passengers. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 12201 This portion of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to section 10(d) of Public Law 92–463. Agenda items are subject to change as priorities dictate. For Further Information Contact: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, NE, M/S K02, Atlanta, Georgia 30341–3724, telephone 770/488– 4655. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 3, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–3346 Filed 3–8–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Advisory Board on Radiation and Worker Health In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting: Name: Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH). Time and Date: 10 a.m.–4 p.m., EST, Tuesday, March 14, 2006. Place: Audio Conference Call via FTS Conferencing. The USA toll free dial in number is 1–866–643–6504, pass code of 9448550. Status: Open to the public, but without a public comment period. Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) of 2000 to advise the President, delegated to the Secretary of Health and Human Services (HHS), on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Board include providing advice on the development of probability of causation guidelines which have been promulgated by HHS as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose E:\FR\FM\09MRN1.SGM 09MRN1 12202 Federal Register / Vol. 71, No. 46 / Thursday, March 9, 2006 / Notices hsrobinson on PROD1PC70 with NOTICES estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2007. Purpose: This board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this Program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Discussed: The agenda for the conference call includes board comments on SEC rule rewrite; reports of working groups on Y–12 Site Profile, Rocky Flats Site Profile, individual dose reconstruction reviews—Sets 2 and 3, Procedures Review (Task 3), and Sanford Cohen & Associates (SC&A) progress on the SEC task; NIOSH update on Bethlehem Steel Site Profile; board correspondence; agenda for the April 25–27, 2006 meeting; and future board/work group schedules and meetings. The agenda is subject to change as priorities dictate. Due to administrative issues that had to be resolved the Federal Register notice is being published on short notice. Contact Person for More Information: Dr. Lewis V. Wade, Executive Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio 45226, telephone 513/533–6825, fax 513/533–6826. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 3, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–3347 Filed 3–8–06; 8:45 am] BILLING CODE 4163–18–P VerDate Aug<31>2005 13:58 Mar 08, 2006 Jkt 208001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Clinical Center; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the NIH Advisory Board for Clinical Research. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: NIH Advisory Board for Clinical Research. Date: March 24, 2006. Time: 10 a.m. to 2 p.m. Agenda: To review proposed 2007 Clinical Center budget. Place: National Institutes of Health, Building 10, 10 Center Drive, 4–2551, CRC Medical Board Room, Bethesda, MD 20892. Contact Person: Maureen E. Gormley, Executive Secretary, Mark O. Hatfield Clinical Research Center, National Institutes of Health, Building 10, Room 6–2551, Bethesda, MD 20892, 301/496–2897. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Dated: February 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2209 Filed 3–8–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee D—Clinical Studies. Date: April 9–10, 2006. Time: 6 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Peter J. Wirth, PhD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8131, Bethesda, MD 20892–8328. 301–496– 7565. pw2q@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2229 Filed 3–8–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Initial Review Group, Research Centers In Minority Institutions Review Committee. Date: March 16, 2006. Time: 8 a.m. to 5 p.m. E:\FR\FM\09MRN1.SGM 09MRN1

Agencies

[Federal Register Volume 71, Number 46 (Thursday, March 9, 2006)]
[Notices]
[Pages 12201-12202]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-3347]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Institute for Occupational Safety and Health Advisory 
Board on Radiation and Worker Health

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Board on Radiation and Worker Health (ABRWH), 
National Institute for Occupational Safety and Health (NIOSH).
    Time and Date: 10 a.m.-4 p.m., EST, Tuesday, March 14, 2006.
    Place: Audio Conference Call via FTS Conferencing. The USA toll 
free dial in number is 1-866-643-6504, pass code of 9448550.
    Status: Open to the public, but without a public comment period.
    Background: The ABRWH was established under the Energy Employees 
Occupational Illness Compensation Program Act (EEOICPA) of 2000 to 
advise the President, delegated to the Secretary of Health and Human 
Services (HHS), on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Board include providing advice on the 
development of probability of causation guidelines which have been 
promulgated by HHS as a final rule, advice on methods of dose 
reconstruction which have also been promulgated by HHS as a final 
rule, advice on the scientific validity and quality of dose

[[Page 12202]]

estimation and reconstruction efforts being performed for purposes 
of the compensation program, and advice on petitions to add classes 
of workers to the Special Exposure Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the board to HHS, which 
subsequently delegated this authority to CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2007.
    Purpose: This board is charged with (a) providing advice to the 
Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this Program; and (c) upon request by the Secretary, 
HHS, advise the Secretary on whether there is a class of employees 
at any Department of Energy facility who were exposed to radiation 
but for whom it is not feasible to estimate their radiation dose, 
and on whether there is reasonable likelihood that such radiation 
doses may have endangered the health of members of this class.
    Matters to be Discussed: The agenda for the conference call 
includes board comments on SEC rule rewrite; reports of working 
groups on Y-12 Site Profile, Rocky Flats Site Profile, individual 
dose reconstruction reviews--Sets 2 and 3, Procedures Review (Task 
3), and Sanford Cohen & Associates (SC&A) progress on the SEC task; 
NIOSH update on Bethlehem Steel Site Profile; board correspondence; 
agenda for the April 25-27, 2006 meeting; and future board/work 
group schedules and meetings.
    The agenda is subject to change as priorities dictate.
    Due to administrative issues that had to be resolved the Federal 
Register notice is being published on short notice.
    Contact Person for More Information: Dr. Lewis V. Wade, 
Executive Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, 
Ohio 45226, telephone 513/533-6825, fax 513/533-6826.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 3, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-3347 Filed 3-8-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.